Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Research Objective
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Introduction
3.1.1 Primary Research Methodology
3.1.2 Secondary Research Methodology
3.1.3 Market Share Analysis
3.1.4 Trade Analysis
3.1.5 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Prevalence of Cirrhosis (Impact Weightage: 35%)
4.2.2 Improvement in Reimbursement Policies (Impact Weightage: 30%)
4.2.3 Increasing Occurrence of Cancer (Impact Weightage: 35%)
4.3 Restraints
4.3.1 Complications associated with the ascites treatment
4.4 Opportunity
4.4.1 Development of Innovative Treatment Options
4.5 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis: Global Ascites Market
5.2.1 R&D and Designing
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-sales Monitoring
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
6 Global Ascites Market by Types
6.1 Introduction
6.2 Transudative Ascites
6.3 Exudate Ascites
7 Global Ascites Market by Diagnosis
7.1 Introduction
7.2 Ultrasound
7.3 CT scan
7.4 Laparoscopy
7.5 Angiography
8 Global Ascites Market by Treatment
8.1 Introduction
8.2 Surgeries
9 Global Ascites Market by End Users
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Ambulatory Surgical Center
9.4 Diagnostic Centres
10 Global Ascites Market by Regions
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.2.2.1 Brazil
10.2.2.2 Colombia
10.2.2.3 Mexico
10.2.2.4 Rest of South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 UK
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 UAE
10.5.1.2 Saudi Arabia
10.5.1.3 Oman
10.5.1.4 Kuwait
10.5.1.5 Qatar
10.5.1.6 Rest of Middle East
10.5.2 Africa
11 Competitive Analysis
11.1 Sequana Medical
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Products
11.1.4 Strategy
11.1.5 Key Developments
11.2 BioVie
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Products
11.2.4 Strategy
11.2.5 Key Developments
11.3 PharmaCyte Biotech Inc.
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Products
11.3.4 Strategy
11.3.5 Key Developments
11.4 Fresenius SE & Co. KGaA
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Products
11.4.4 Strategy
11.4.5 Key Developments
11.5 BD
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Products
11.5.4 Strategy
11.5.5 Key Developments
11.6 GI Supply
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Products
11.6.4 Strategy
11.6.5 Key Developments
11.7 Medtronic
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Products
11.7.4 Strategy
11.7.5 Key Developments
12 Conclusion
12.1 Key Findings
12.1.1 From CEO's View Point
13 Appendix
13.1 Discussion Blue Print